Items where Author is "Fink, Doug L"
Number of items: 7.
2022
SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa. (2022)
Abdullahi, Adam; Oladele, David; Owusu, Michael; Kemp, Steven A; Ayorinde, James; Salako, Abideen; Fink, Douglas; Ige, Fehintola; Ferreira, Isabella ATM; Meng, Bo; Sylverken, Augustina Angelina; Onwuamah, Chika; Boadu, Kwame Ofori; Osuolale, Kazeem; Frimpong, James Opoku; Abubakar, Rufai; Okuruawe, Azuka; Abdullahi, Haruna Wisso; Liboro, Gideon; Agyemang, Lawrence Duah; Ayisi-Boateng, Nana Kwame; Odubela, Oluwatosin; Ohihoin, Gregory; Ezechi, Oliver; Kamasah, Japhet Senyo; Ameyaw, Emmanuel; Arthur, Joshua; Kyei, Derrick Boakye; Owusu, Dorcas Ohui; Usman, Olagoke; Mogaji, Sunday; Dada, Adedamola; Agyei, George; Ebrahimi, Soraya; Gutierrez, Lourdes Ceron; Aliyu, Sani H; Doffinger, Rainer; Audu, Rosemary; Adegbola, Richard; Mlcochova, Petra; Phillips, Richard Odame; Solako, Babatunde Lawal; Gupta, Ravindra K
HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65. (2022)
Fink, Douglas L; Cai, James; Whelan, Matthew VX; Monit, Christopher; Maluquer de Motes, Carlos; Towers, Greg J; Sumner, Rebecca P
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. (2022)
Fink, Douglas L; Callaby, Helen; Luintel, Akish; Beynon, William; Bond, Helena; Lim, Eleanor Y; Gkrania-Klotsas, Effrossyni; Heskin, Jospeh; Bracchi, Margherita; Rathish, Balram; Milligan, Iain; O'Hara, Geraldine; Rimmer, Stephanie; Peters, Joanna R; Payne, Lara; Mody, Nisha; Hodgson, Bethany; Lewthwaite, Penny; Lester, Rebecca; Woolley, Stephen D; Sturdy, Ann; Whittington, Ashley; Johnson, Leann; Jacobs, Nathan; Quartey, John; Ai Payne, Brendan; Crowe, Stewart; Elliott, Ivo Am; Harrison, Thomas; Cole, Joby; Beard, Katie; Cusack, Tomas-Paul; Jones, Imogen; Banerjee, Rishi; Rampling, Tommy; Specialist and High Consequence Infectious Diseases Centres Netw; Dunning, Jake
2020
Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital. (2020)
Fink, DL; Khan, PY; Goldman, N; Cai, J; Hone, L; Mooney, C; El-Shakankery, KH; Sismey, G; Whitford, V; Marks, M; Thomas, S
HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport. (2020)
Khan, Hataf; Sumner, Rebecca P; Rasaiyaah, Jane; Tan, Choon Ping; Rodriguez-Plata, Maria Teresa; Van Tulleken, Chris; Fink, Douglas; Zuliani-Alvarez, Lorena; Thorne, Lucy; Stirling, David; Milne, Richard Sb; Towers, Greg J
